用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biomarkers for Alzheimer’s Disease Drug Development; Robert Perneczky Book 2018 Springer Science+Business Media, LLC 2018 Alzheimer’s dise

[复制链接]
查看: 27855|回复: 49
发表于 2025-3-21 19:28:00 | 显示全部楼层 |阅读模式
期刊全称Biomarkers for Alzheimer’s Disease Drug Development
影响因子2023Robert Perneczky
视频videohttp://file.papertrans.cn/188/187795/187795.mp4
发行地址Includes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts
学科分类Methods in Molecular Biology
图书封面Titlebook: Biomarkers for Alzheimer’s Disease Drug Development;  Robert Perneczky Book 2018 Springer Science+Business Media, LLC 2018 Alzheimer’s dise
影响因子.This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimer’s disease field. Chapters guide readers through innovative approaches to the discovery of novel biomarkers in cerebrospinal fluid, innovation in blood-based biomarkers, a comprehensive overview of magnetic resonance imaging and molecular imaging approaches and their value for developing drugs for Alzheimer’s disease, cutting-edge developments in neuropathology and their relevance for Alzheimer’s disease trials, novel genomic strategies for biomarker development, and related topics including neuropsychological testing and advanced analytical methods.Written in the highly successful .Methods in Molecular Biology .series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls... ..Authoritative and cutting-edge, .Biomarkers for Alzheimer‘s Disease Drug Development .aims to ensure successful results in the further study of this vital field. .
Pindex Book 2018
1 Front Matter
Abstract
2
Abstract
3 Epidemiology of Dementia: The Burden on Society, the Challenges for Research Frank J. Wolters,MA Ikram
Abstract
4 Population-Based Approaches to Alzheimer’s Disease Prevention Robert Perneczky
Abstract
5 Systems Biology Methods for Alzheimer’s Disease Research Toward Molecular Signatures, Subtypes, and Juan I. Castrillo,Simone Lista,Harald Hampel,Craig W. Ritchie
Abstract
6
Abstract
7 CSF Lipidomics Analysis: High-Resolution Mass Spectrometry Analytical Platform Paul L. Wood,Randall L. Woltjer
Abstract
8 CSF N-Glycomics Using MALDI MS Techniques in Alzheimer’s Disease Angelo Palmigiano,Angela Messina,Rosaria Ornella Bua,Rita Barone,Luisa Sturiale,Mario Zappia,Domenic
Abstract
9 MicroRNA Profiling of Alzheimer’s Disease Cerebrospinal Fluid Johannes Denk,Holger Jahn
Abstract
10
Abstract
11 Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-β in Human Blood Plasma Jonathan Vogelgsang,Jens Wiltfang,Hans W. Klafki
Abstract
12 Mass Spectrometry-Based Metabolomic Multiplatform for Alzheimer’s Disease Research Raúl González-Domínguez,Álvaro González-Domínguez,Ana Sayago,Ángeles Fernández-Recamales
Abstract
13 Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Withi Filippo Baldacci,Simone Lista,Sid E. O’Bryant,Roberto Ceravolo,Nicola Toschi,Harald Hampel,for the A
Abstract
14
Abstract
15 Functional Magnetic Resonance Imaging in Alzheimer’ Disease Drug Development Stefan Holiga,Ahmed Abdulkadir,Stefan Klöppel,Juergen Dukart
Abstract
16 Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies Carles Falcon,Grégory Operto,José Luis Molinuevo,Juan Domingo Gispert
Abstract
17 Hybrid PET-MRI in Alzheimer’s Disease Research Ismini C. Mainta,Maria I. Vargas,Sara Trombella,Giovanni B. Frisoni,Paul G. Unschuld,Valentina Garib
Abstract
18
Abstract
19 Amyloid PET Imaging: Standardization and Integration with Other Alzheimer’s Disease Biomarkers Silvia Morbelli,Matteo Bauckneht
Abstract
20 The Use of 18F-FDG PET in the Diagnostic Workup of Alzheimer’s Dementia Marion M. Ortner
Abstract
书目名称Biomarkers for Alzheimer’s Disease Drug Development影响因子(影响力)




书目名称Biomarkers for Alzheimer’s Disease Drug Development影响因子(影响力)学科排名




书目名称Biomarkers for Alzheimer’s Disease Drug Development网络公开度




书目名称Biomarkers for Alzheimer’s Disease Drug Development网络公开度学科排名




书目名称Biomarkers for Alzheimer’s Disease Drug Development被引频次




书目名称Biomarkers for Alzheimer’s Disease Drug Development被引频次学科排名




书目名称Biomarkers for Alzheimer’s Disease Drug Development年度引用




书目名称Biomarkers for Alzheimer’s Disease Drug Development年度引用学科排名




书目名称Biomarkers for Alzheimer’s Disease Drug Development读者反馈




书目名称Biomarkers for Alzheimer’s Disease Drug Development读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:00:02 | 显示全部楼层
发表于 2025-3-22 03:59:55 | 显示全部楼层
发表于 2025-3-22 04:34:51 | 显示全部楼层
Joachim Tries,Rüdiger Reinhardt, an update on advanced systems biology methods and strategies for holistic studies of multifactorial diseases—particularly AD—is presented. This includes next-generation genomics, neuroimaging and multi-omics methods, experimental and computational approaches, relevant disease models, and latest ge
发表于 2025-3-22 12:33:12 | 显示全部楼层
Joachim Tries,Rüdiger Reinhardtate for an efficient primary care management. A limitation to the development of a large-scale blood-screening biomarker-based test is the traditional application of clinically descriptive criteria for the categorization of single late-stage ND constructs. These are genetically and biologically hete
发表于 2025-3-22 14:38:06 | 显示全部楼层
Perspektiven kritischer Sozialer Arbeitseful tool when the cause for dementia remains unclear and different diagnosis would lead to different treatment approaches. Due to the lack of treatment options in pre-dementia stages, the use of .F-FDG PET is currently not recommended for these cases in a purely clinical setting.
发表于 2025-3-22 19:59:36 | 显示全部楼层
发表于 2025-3-22 21:38:09 | 显示全部楼层
发表于 2025-3-23 03:25:23 | 显示全部楼层
发表于 2025-3-23 07:51:12 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-12 18:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表